Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL network phase II trial

Tools

Item Type:	Letter
Title:	Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL network phase II trial
Creators Name:	Ferrero, S., Pastore, A., Scholz, C.W., Forstpointner, R., Pezzutto, A., Bergmann, L., Truemper, L., Finke, J., Keller, U., Ghione, P., Passera, R., Hiddemann, W., Weigert, O., Unterhalt, M. and Dreyling, M.
Keywords:	Europe, Follow-Up Studies, Local Neoplasm Recurrence, Mantle-Cell Lymphoma, Monoclonal Antibodies, Neoplasm Drug Resistance, Neoplasm Staging, Prognosis, Prospective Studies, Radioimmunotherapy, Survival Rate, Yttrium Radioisotopes
Source:	Leukemia
ISSN:	0887-6924
Publisher:	Nature Publishing Group
Volume:	30
Number:	4
Page Range:	984-987
Date:	April 2016
Official Publication:	https://doi.org/10.1038/leu.2015.215
PubMed:	View item in PubMed

Repository Staff Only: item control page